APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease
S Datta, BM Antonio, NH Zahler… - The Journal of …, 2024 - Am Soc Clin Investig
Two coding variants of apolipoprotein L1 (APOL1), called G1 and G2, explain much of the
excess risk of kidney disease in African Americans. While various cytotoxic phenotypes have …
excess risk of kidney disease in African Americans. While various cytotoxic phenotypes have …
Molecular mechanisms of diabetic nephropathy: A narrative review
T Sun, Y Guo, Y Su, S Shan, W Qian… - Cell Biology …, 2024 - Wiley Online Library
Diabetic nephropathy (DN) is the predominant secondary nephropathy resulting in global
end‐stage renal disease. It is attracting significant attention in both domestic and …
end‐stage renal disease. It is attracting significant attention in both domestic and …
[PDF][PDF] The role of intercellular communication in diabetic nephropathy
B Wang, Y Xiong, X Deng, S Gong, Y Wang… - Frontiers in …, 2024 - frontiersin.org
Diabetic nephropathy (DN), characterized by renal interstitial inflammation and fibrosis, is
the key factor of end-stage renal disease (ESRD)(1). The global rate of ESRD among …
the key factor of end-stage renal disease (ESRD)(1). The global rate of ESRD among …
Interferon-γ induces combined pyroptotic angiopathy and APOL1 expression in human kidney disease
BA Juliar, IB Stanaway, F Sano, H Fu, KD Smith… - Cell Reports, 2024 - cell.com
Elevated interferon (IFN) signaling is associated with kidney diseases including COVID-19,
HIV, and apolipoprotein-L1 (APOL1) nephropathy, but whether IFNs directly contribute to …
HIV, and apolipoprotein-L1 (APOL1) nephropathy, but whether IFNs directly contribute to …
The NLRP3 inflammasome in burns: a novel potential therapeutic target
H Li, J Zhao, L Cao, Q Luo, C Zhang, L Zhang - Burns & Trauma, 2024 - academic.oup.com
Burns are an underestimated serious injury negatively impacting survivors physically,
psychologically and economically, and thus are a considerable public health burden …
psychologically and economically, and thus are a considerable public health burden …
Correspondence on:'SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy'by Zhao et al
We read with interest and surprise the study of Zhao et al. on the therapeutic effects of the
SGLT2 inhibitor empagliflozin in systemic lupus erythematosus (SLE) and lupus-like …
SGLT2 inhibitor empagliflozin in systemic lupus erythematosus (SLE) and lupus-like …
Response to: Correspondence on 'SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy'by Zhao et …
Y Qi - Annals of the Rheumatic Diseases, 2024 - ard.bmj.com
We would like to thank Soler, Jacobs-Cachá and Anders 1 for their interest in our work on
sodium glucose cotransporter (SGLT) 2 inhibitors' treatment in lupus nephritis (LN). 2 We …
sodium glucose cotransporter (SGLT) 2 inhibitors' treatment in lupus nephritis (LN). 2 We …